Urologia · 2026
Totally tubeless percutaneous nephrolithotomy versus standard percutaneous nephrolithotomy in the treatment of renal stones: An updated systematic review and meta-analysis.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nisar Mudasar, Iqbal Rabia Javed, Rasool Muhammad Mujtaba, Saleem Noor Ul Ain, Raza Ahmed, Khan Anum Zia, Kadian Bhopesh, Rana Muhammad Fakhir Iftikhar, Prasad Preety, Kumar Naveen
Аннотация
BACKGROUND: Percutaneous nephrolithotomy (PCNL) is a standard surgical procedure for kidney stone removal. Totally tubeless PCNL is a variation in technique in which neither an indwelling ureteric stent nor a nephrostomy tube is placed postoperatively. This meta-analysis compares the efficacy and safety of totally tubeless PCNL with standard PCNL.
METHODS: PubMed, Scopus, Cochrane Library, and clinicaltrials.gov databases were searched until January 2025. The primary outcomes were stone-free rate, operative time and hospital stay while secondary outcomes were hemoglobin (Hb) drop, total complication rates and blood transfusion. Effect sizes were calculated using fixed and random-effects models, expressed as mean difference (MD) or risk ratio (RR) with 95% confidence intervals (CIs).
RESULTS: 21 studies with 2837 patients were included in this study. Totally tubeless PCNL was associated with significantly shorter operative time (WMD) = -7.96, 95% CI = -12.95 to -2.98, p < 0.01) and reduced hospital stay (WMD = -1.53, 95% CI = -2.12 to -0.93, p < 0.01). The stone-free rate was comparable between the two techniques (RR = 1.02, 95% CI = 0.95-1.10, p = 0.51). A significant reduction in total complications was observed in the totally tubeless group (RR: 0.63, 95% CI: 0.44-0.90, p = 0.02). However, no significant differences were observed in terms of hemoglobin drop (WMD: -0.36, 95% CI: -0.79 to 0.08, p = 0.11) or blood transfusion rates (RR: 0.77, 95% CI: 0.45-1.32, p = 0.30). Meta-regression suggested that stone size was not a significant predictor of procedural success or duration.
CONCLUSION: Compared to standard PCNL, totally tubeless PCNL shortens operation time and hospital stay and lowers complication rates, with equivalent stone-free efficacy. These findings support its use as a preferred technique for appropriately selected patients.
METHODS: PubMed, Scopus, Cochrane Library, and clinicaltrials.gov databases were searched until January 2025. The primary outcomes were stone-free rate, operative time and hospital stay while secondary outcomes were hemoglobin (Hb) drop, total complication rates and blood transfusion. Effect sizes were calculated using fixed and random-effects models, expressed as mean difference (MD) or risk ratio (RR) with 95% confidence intervals (CIs).
RESULTS: 21 studies with 2837 patients were included in this study. Totally tubeless PCNL was associated with significantly shorter operative time (WMD) = -7.96, 95% CI = -12.95 to -2.98, p < 0.01) and reduced hospital stay (WMD = -1.53, 95% CI = -2.12 to -0.93, p < 0.01). The stone-free rate was comparable between the two techniques (RR = 1.02, 95% CI = 0.95-1.10, p = 0.51). A significant reduction in total complications was observed in the totally tubeless group (RR: 0.63, 95% CI: 0.44-0.90, p = 0.02). However, no significant differences were observed in terms of hemoglobin drop (WMD: -0.36, 95% CI: -0.79 to 0.08, p = 0.11) or blood transfusion rates (RR: 0.77, 95% CI: 0.45-1.32, p = 0.30). Meta-regression suggested that stone size was not a significant predictor of procedural success or duration.
CONCLUSION: Compared to standard PCNL, totally tubeless PCNL shortens operation time and hospital stay and lowers complication rates, with equivalent stone-free efficacy. These findings support its use as a preferred technique for appropriately selected patients.